Loading quotes...
Forecast
| Buy |
1 |
| Hold |
0 |
| Sell |
0 |
News Go to news feed
Healthcare Triangle meets NASDAQ minimum requirement again through stock issuance
Healthcare Triangle issued 12,546,540 common shares on July 24 to settle the acquisition of Teyame AI and a stock swap with SecureKloud. As a result, total shares outstanding increased to 14,644,322 as of July 28 and the market value of the listed securities rose to about $23.9 million (closing price $1.63). This places the company above the NASDAQ minimum requirement of $5 million effective July 22, although final compliance will be determined by day-to-day price and share-count reviews. » More on de.investing.com
Healthcare Triangle appoints Sumit Ganguli CEO of AI subsidiary Purpose Health
Healthcare Triangle names Sumit Ganguli chairman and CEO of Purpose Health, its wholly owned subsidiary specializing in AI-enabled technology services for healthcare. Purpose Health will provide AI infrastructure and solutions for providers, payers, life sciences and medtech, focusing on AI-driven IT managed services, strategic joint ventures and multi-year recurring revenue. Ganguli brings more than 30 years of experience in IT and health technology and will drive expansion and partnerships with EHR vendors, cloud partners and AI companies. » More on de.investing.com
Healthcare Triangle secures $3.6 million through private placement of convertible notes
Healthcare Triangle completed a private placement of senior convertible notes with gross proceeds of about $3.6 million. The notes have an aggregate principal amount of $4.235 million, a 15% discount (Disagio) and mature on December 12, 2026; conversion is possible no earlier than six months after issuance at a price equal to 85% of the volume-weighted average price of the three trading days before the conversion notice. The company, which has a market capitalization of only $4.93 million and reported negative free cash flow of $17.86 million, intends to use the net proceeds to repay existing liabilities, for potential strategic acquisitions and for working capital. » More on de.investing.com
Financials
| (EUR) | June 2026 | |
|---|---|---|
| Revenue | 8.05M | 166.84% |
| Gross profit | 1.81M | 332.13% |
| Net profit | -3.87M | 233.30% |
| EBITDA | -3.31M | 189.32% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €807.4K |
Number of shares | 1.16M |
52-week high/low | €192.63 - €0.70 |
| Dividends | No |
Beta | 1.12 |
P/E ratio | -0.01 |
PEG ratio | 0.00 |
P/B ratio | 0.05 |
P/S ratio | 0.04 |
Company profile
| Name | Healthcare Triangle Inc [Common Shares] |
| CEO | Lakshmanan Kannappan |
| Employees | 41 |
Discover assets
Shareholders of Healthcare Triangle Inc [Common Shares] also invest in the following assets
![Healthcare Triangle Inc [Common Shares] Logo](https://img.parqet.com/assets/fallback.png)

